Cardioprotective Cryptides Derived from Fish and Other Food Sources: Generation, Application, and Future Markets

被引:27
作者
Mora, Leticia [1 ]
Hayes, Maria [2 ]
机构
[1] CSIC, Inst Agroquim & Tecnol Alimentos, Valencia 46980, Spain
[2] Teagasc Food Res Ctr, Food BioSci Dept, Dublin 15, Ireland
关键词
renin angiotensin aldosterone system; cryptides; antithrombotic; ACE and ACE2 inhibitory; renin inhibitory; platelet activating factor acetylhydrolase inhibitory; blood-brain barrier; bioavailability; European Food Safety Authority; hydrophilic interaction liquid chromatorgraphy; I-CONVERTING-ENZYME; ACE-INHIBITORY PEPTIDE; BIOACTIVE PEPTIDES; PROTEIN HYDROLYSATE; MUSCLE PROTEIN; BLOOD-PRESSURE; STRUCTURAL REQUIREMENTS; OPIOID-PEPTIDES; FRAME PROTEIN; DPP-IV;
D O I
10.1021/jf505019z
中图分类号
S [农业科学];
学科分类号
082806 [农业信息与电气工程];
摘要
The primary function of dietary protein is to provide amino acids for protein synthesis. However, protein is also a source of latent bioactive peptides or cryptides with potential health benefits including the control and regulation of blood pressure. Hypertension or high blood pressure is one of the major, controllable risk factors in the development of cardiovascular disease (CVD), and it is also implicated in the development of myocardial infarction, heart failure, and end-stage diabetes. Cryptides can act on various systems of the body including the circulatory, gastrointestinal (GI), nervous, skeletal, and respiratory systems. A number of studies carried out to date have examined the health benefits of food protein isolates and hydrolysates. This review provides an overview of existing blood pressure regulating peptides and products derived from fish and other protein sources and hydrolysates. It discusses the methods used currently to generate and identify cryptides from these sources and their application in food and pharmaceutical products. It also looks at the current market for protein-derived peptides and peptide-containing products, legislation governing their use, and the future development of research in this area.
引用
收藏
页码:1319 / 1331
页数:13
相关论文
共 138 条
[1]
Scientific Opinion on the safety of 'Sardine Peptide Product' [J].
Agostoni, Carlo Virginio ;
Bresson, Jean-Louis ;
Fairweather-Tait, Susan ;
Flynn, Albert ;
Golly, Ines ;
Heinonen, Marina ;
Korhonen, Hannu ;
Lagiou, Pagona ;
Lovik, Martinus ;
Marchelli, Rosangela ;
Martin, Ambroise ;
Moseley, Bevan ;
Neuhaeuser-Berthold, Monika ;
Przyrembel, Hildegard ;
Sanz, Yolanda ;
Salminen, Seppo ;
Strain, John J. ;
Strobel, Stephan ;
Tetens, Inge ;
Tome, Daniel ;
van den Berg, Henk ;
van Loveren, Hendrik ;
Verhagen, Hans .
EFSA JOURNAL, 2010, 8 (07)
[2]
Industrial-scale manufacturing of pharmaceutical-grade bioactive peptides [J].
Agyei, Dominic ;
Danquah, Michael K. .
BIOTECHNOLOGY ADVANCES, 2011, 29 (03) :272-277
[3]
Metabolic Syndrome: Comparison of Occurrence Using Three Definitions in Hypertensive Patients [J].
Akintunde, Adeseye ;
Ayodele, Olugbenga ;
Akinwusi, Patience ;
Opadijo, George .
CLINICAL MEDICINE & RESEARCH, 2011, 9 (01) :26-31
[4]
Peptide inhibitors for angiotensin I-converting enzyme from enzymatic hydrolysates of porcine skeletal muscle proteins [J].
Arihara, K ;
Nakashima, Y ;
Mukai, T ;
Ishikawa, S ;
Itoh, M .
MEAT SCIENCE, 2001, 57 (03) :319-324
[5]
Arihara K, 2005, 50 INT C MEAT SCI TE, P236
[6]
The renin-angiotensin aldosterone system: Pathophysiological role and pharmacologic inhibition [J].
Atlas, Steven A. .
JOURNAL OF MANAGED CARE PHARMACY, 2007, 13 (08) :S9-S20
[7]
Measuring Angiotensin-I Converting Enzyme Inhibitory Activity by Micro Plate Assays: Comparison Using Marine Cryptides and Tentative Threshold Determinations with Captopril and Losartan [J].
Ben Henda, Yesmine ;
Labidi, Anis ;
Arnaudin, Ingrid ;
Bridiau, Nicolas ;
Delatouche, Regis ;
Maugard, Thierry ;
Piot, Jean-Marie ;
Sannier, Frederic ;
Thiery, Valerie ;
Bordenave-Juchereau, Stephanie .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2013, 61 (45) :10685-10690
[8]
HPLC preparation of fish waste hydrolysate fractions. Effect on guinea pig ileum and ace activity [J].
Bordenave, S ;
Fruitier, I ;
Ballandier, I ;
Sannier, F ;
Gildberg, A ;
Batista, F ;
Piot, JM .
PREPARATIVE BIOCHEMISTRY & BIOTECHNOLOGY, 2002, 32 (01) :65-77
[9]
Byun HG, 2002, J BIOCHEM MOL BIOL, V35, P239
[10]
Bovine casein hydrolysate (C12 Peptide) reduces blood pressure in prehypertensive subjects [J].
Cadee, Jenny A. ;
Chang, Chou-Yue ;
Chen, Chien-Wei ;
Huang, Chien-Ning ;
Chen, Su-Lin ;
Wang, Chin-Kun .
AMERICAN JOURNAL OF HYPERTENSION, 2007, 20 (01) :1-5